[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2568878B1 - Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique - Google Patents

Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique

Info

Publication number
FR2568878B1
FR2568878B1 FR8412580A FR8412580A FR2568878B1 FR 2568878 B1 FR2568878 B1 FR 2568878B1 FR 8412580 A FR8412580 A FR 8412580A FR 8412580 A FR8412580 A FR 8412580A FR 2568878 B1 FR2568878 B1 FR 2568878B1
Authority
FR
France
Prior art keywords
phenylpiperazinylethylamine
ethoxy
novel
preparation
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8412580A
Other languages
English (en)
Other versions
FR2568878A1 (fr
Inventor
Marie-Helene Creuzet
Claude Feniou
Francoise Guichard
Gisele Prat
Henri Pontagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Priority to FR8412580A priority Critical patent/FR2568878B1/fr
Priority to EP85450017A priority patent/EP0173634B1/fr
Priority to DE8585450017T priority patent/DE3564683D1/de
Priority to MA20727A priority patent/MA20501A1/fr
Priority to PT80914A priority patent/PT80914B/pt
Priority to OA58659A priority patent/OA08259A/fr
Priority to JP60173085A priority patent/JPS6163655A/ja
Priority to US06/763,257 priority patent/US4721715A/en
Priority to CA000488250A priority patent/CA1253153A/fr
Priority to ES545980A priority patent/ES8604912A1/es
Publication of FR2568878A1 publication Critical patent/FR2568878A1/fr
Application granted granted Critical
Publication of FR2568878B1 publication Critical patent/FR2568878B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR8412580A 1984-08-07 1984-08-07 Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique Expired FR2568878B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8412580A FR2568878B1 (fr) 1984-08-07 1984-08-07 Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique
EP85450017A EP0173634B1 (fr) 1984-08-07 1985-07-23 Nouveaux dérivés d'(arylpipérazinyléthylaminoéthoxy)-4 phénol, leur méthode de préparation et leur application thérapeutique
DE8585450017T DE3564683D1 (en) 1984-08-07 1985-07-23 4-(arylpiperazinylethylaminoethoxy) phenol derivatives, process for their preparation and their therapeutical application
MA20727A MA20501A1 (fr) 1984-08-07 1985-08-01 Nouveaux d'(arypiperazinylethylaminolthoxy)-4 phenol leur methode de preparation
PT80914A PT80914B (pt) 1984-08-07 1985-08-05 Processo para a preparacao de novos derivados 4-(arilpiperaziniletilaminoetoxi) fenol, e metodo de aplicacao terapeutica
OA58659A OA08259A (fr) 1984-08-07 1985-08-05 Nouveaux dérivés d'(arylpipérazinylaminoéthoxy)- phénol, leur méthode de préparation et leur application thérapeutique.
JP60173085A JPS6163655A (ja) 1984-08-07 1985-08-06 新規な４−（アリ−ルピペラジニルエチルアミノエトキシ）フエノ−ル誘導体、その製法及び治療上への応用
US06/763,257 US4721715A (en) 1984-08-07 1985-08-07 Derivatives of 4-(arylpiperazinyl-ethylaminoethoxy) phenol useful for effecting hypolipidemic therapy or cardiovascular therapy
CA000488250A CA1253153A (fr) 1984-08-07 1985-08-07 Derives d'(arylpiperazinylethylaminoethoxy)-4 phenol, leur methode de preparation et leur application therapeutique
ES545980A ES8604912A1 (es) 1984-08-07 1985-08-07 Procedimiento de preparacion de nuevos derivados de (arilpi-peraziniletilaminoetoxi)-4 fenol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8412580A FR2568878B1 (fr) 1984-08-07 1984-08-07 Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique

Publications (2)

Publication Number Publication Date
FR2568878A1 FR2568878A1 (fr) 1986-02-14
FR2568878B1 true FR2568878B1 (fr) 1986-11-21

Family

ID=9306928

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8412580A Expired FR2568878B1 (fr) 1984-08-07 1984-08-07 Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique

Country Status (3)

Country Link
US (1) US4721715A (fr)
JP (1) JPS6163655A (fr)
FR (1) FR2568878B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882330A (en) * 1986-11-21 1989-11-21 A. H. Robins Company, Incorporated 1-aryloxy-4-[((4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
FR2632641B1 (fr) * 1988-06-13 1990-10-12 Irceba ((aryl-4-piperazinyl-1)-2 ethoxy)-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif
HUT70031A (en) * 1992-11-30 1995-09-28 Sankyo Co Alfa, omega-diarylalkane derivatives, their preparation and pharmaceutical compositions containing them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239520A (en) * 1961-11-20 1966-03-08 Nl Combinatie Chem Ind N-(monocarbocyclic aryloxy-lower alkyl)-n' (diloweralkyl, or heterocyclic)-lower alkylene diamines
FR1349636A (fr) * 1962-02-26 1964-01-17 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la pipérazine, et procédé de préparation
FR2446M (fr) * 1962-02-26 1964-04-06 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la pipérazine.
GB1053301A (fr) * 1963-01-14
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof
US3951983A (en) * 1970-11-10 1976-04-20 Pfizer Inc. Phenoxypropanolpiperazines
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
GB1583372A (en) * 1977-04-04 1981-01-28 Degussa 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl piperazine derivatives

Also Published As

Publication number Publication date
FR2568878A1 (fr) 1986-02-14
JPS6163655A (ja) 1986-04-01
US4721715A (en) 1988-01-26

Similar Documents

Publication Publication Date Title
FR2543550B1 (fr) Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
BE892270A (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
FR2493848B2 (fr) Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
FR2543140B1 (fr) Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
BE891526A (fr) Nouveaux derives aminoalcoyl heterocycliques, leur procede de preparation et leur application en therapeutique
BE888417A (fr) Nouveaux derives de theophyllinylmethyldioxolane, leur procedes de preparation et leur application en therapeutique,
FR2580281B1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
FR2568878B1 (fr) Nouveaux derives de (phenylpiperazinylethylamine ethoxy)-4 phenol, leur methode de preparation et leur application therapeutique
FR2654106B1 (fr) Derives phosphores de cytosine, leur preparation et leur application en therapeutique.
BE895464A (fr) Nouveaux derives aminoalkoxy aromatiques leur procede de preparation et leur application en therapeutique
FR2516509B1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
PT80914A (fr) Methode de preparation des nouveaux derives d'(arylpiperaziniletilaminoetoxi)-4-fenol et leur application therapeutique
FR2477142B1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et leur application en therapeutique
MC1387A1 (fr) Nouveaux derives de phenoxyaminopropanol et leur preparation
BE887430A (fr) Nouveaux derives de l'indane, leur preparation et leur application en therapeutique
DZ851A1 (fr) Nouveaux dérivés de la pyridine et leur procédé depréparation.
FR2582302B2 (fr) Nouvelles (amino-1 ethylidenyl)-2 indanediones-1,3 substituees, leur methode de preparation et leur application therapeutique
FR2622889B1 (fr) Nouveaux derives de demethoxy-4 anthracycline et leur application en therapeutique
MA20725A1 (fr) Nouveaux benzamides, leur procede de preparation et leur application
FR2584402B2 (fr) Nouveaux derives d'(arylpiperazinylethylaminoethoxy)-4 phenols, leur methode de preparation et leur application therapeutique
FR2565234B1 (fr) Nouveaux polysilanes non ramifies, leur preparation et leur application
FR2570697B1 (fr) Nouveaux hydroxy-thia alcenes, leur procede de preparation et applications
FR2534255B1 (fr) Nouveaux derives de la 4-aroylamino piperidine, leur procede de preparation et leur application en therapeutique
FR2557103B1 (fr) Nouveaux cycloalkylamino-1 tertiobutylamino-3 propanols-2, leur methode de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse